Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2001 Sep;132(3):425-7.
doi: 10.1016/s0002-9394(01)01010-8.

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

Affiliations
Case Reports

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

J B Jonas et al. Am J Ophthalmol. 2001 Sep.

Abstract

Purpose: To report the clinical outcome of a diabetic patient with macular edema treated with an intravitreal injection of crystalline cortisone.

Methods: Interventional case report. A 73-year-old patient with diabetes mellitus presented with clinically significant diffuse macular edema caused by nonproliferative diabetic retinopathy. Despite grid laser coagulation in the macular region, cystoid macular edema progressed, and within 6 months before the cortisone injection, visual acuity declined from 0.25 to 0.16 and, finally, to 0.10. The patient received a single intravitreal injection of triamcinolone acetonide with topical anesthesia.

Results: After the intravitreal injection of triamcinolone acetonide, visual acuity improved from 0.10 to 0.40 during the follow-up period spanning 5 months. Intraocular pressure increased to values up to 30 mm Hg before antiglaucomatous treatment.

Conclusion: Intravitreal injection of triamcinolone acetonide may be useful for treatment of diabetic macular edema resistant to conventional therapy.

PubMed Disclaimer

Similar articles

Cited by

Publication types

LinkOut - more resources